Sharon Mates
37Patents
22h-index
12Co-inventors
82Inventor score
Filing activity: Aug 31, 1992 → Oct 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8598119B2 | Methods and compositions for sleep disorders and other disorders | Chemistry; Metallurgy | 103 | Active |
| US9168258B2 | Methods and compositions for sleep disorders and other disorders | Chemistry; Metallurgy | 88 | Active |
| US8993572B2 | Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives | Chemistry; Metallurgy | 85 | Active |
| US9616061B2 | Methods and compositions for sleep disorders and other disorders | Chemistry; Metallurgy | 76 | Active |
| US9371324B2 | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders | Chemistry; Metallurgy | 75 | Active |
| US9428506B2 | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders | Chemistry; Metallurgy | 67 | Active |
| US9745300B2 | Organic compounds | Chemistry; Metallurgy | 65 | Active |
| US9956227B2 | Method for the treatment of residual symptoms of schizophrenia | Human Necessities | 63 | Active |
| US10077267B2 | Organic compounds | Chemistry; Metallurgy | 55 | Active |
| US10117867B2 | Methods and compositions for sleep disorders and other disorders | Chemistry; Metallurgy | 48 | Active |
| US10322134B2 | Methods | Human Necessities | 40 | Active |
| US5425946A | Vaccines against group C Neisseria meningitidis | Emerging Cross-Sectional Technologies | 31 | Expired |
| US10960009B2 | Methods of treating schizophrenia and depression | Human Necessities | 30 | Active |
| US11026951B2 | Methods of treating bipolar disorder | Human Necessities | 30 | Active |
| US10702522B2 | Methods and compositions for sleep disorders and other disorders | Chemistry; Metallurgy | 30 | Active |
| US10960010B2 | Pharmaceutical compositions for sustained or delayed release | Human Necessities | 30 | Active |
| US11053245B2 | Methods | Chemistry; Metallurgy | 28 | Active |
| US10245260B2 | Organic compounds | Chemistry; Metallurgy | 27 | Active |
| US11124514B2 | Compositions and methods | Chemistry; Metallurgy | 27 | Active |
| US9006258B2 | Method of treating female sexual dysfunction with a PDE1 inhibitor | Human Necessities | 25 | Active |
| US11376249B2 | Organic compounds | Human Necessities | 23 | Active |
| US9198924B2 | Organic compounds | Human Necessities | 22 | Active |
| US10799500B2 | Organic compounds | Chemistry; Metallurgy | 22 | Active |
| US10597394B2 | Organic compounds | Chemistry; Metallurgy | 21 | Active |
| US10899762B2 | Organic compounds | Chemistry; Metallurgy | 20 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.